Vascular Grafts Market Analysis & Forecast: 2026-2033

Vascular Grafts Market Size and Forecast – 2026 – 2033

The global vascular grafts market is projected to grow from about USD 7.5 billion in 2026 to USD 9.65 billion by 2033, expanding at a 3.26 % CAGR between 2026 and 2033, reflecting steady demand driven by rising cardiovascular and renal diseases.

Global Vascular Grafts Market Overview

Vascular grafts are medical devices used to replace, bypass, or repair damaged blood vessels, primarily arteries and veins. They restore normal blood flow in conditions like peripheral artery disease, aneurysms, or during hemodialysis access creation. Grafts can be synthetic (e.g., PTFE, Dacron) or biological (autologous veins or animal-derived grafts). Key advantages include improved circulation and reduced risk of vessel rupture, while challenges involve graft rejection, thrombosis, or infection. Innovations focus on bioengineered and tissue-engineered grafts to enhance compatibility and durability. The increasing prevalence of cardiovascular diseases and aging populations drives steady growth in the vascular grafts market globally.

Key Takeaways

• By Product type, Synthetic grafts dominate the market, holding around ~65% share.

• The vascular grafts market is increasingly shaped by endovascular technologies, with Endovascular stent grafts capturing ~64% share.

• In the vascular graft market, Hospitals dominate end‑user demand, holding roughly ~65% share.  

• The North America vascular grafts market leads globally, holding about ~40% share of the global market.

• The Asia Pacific vascular grafts market is among the fastest‑growing globally, representing around ~25% of the global market share.

• The U.S. vascular grafts market is valued at roughly USD 616.6 M in 2026 and is projected to grow at a ~6.8 % CAGR.

• The Germany vascular grafts market is Europe’s largest, holding an estimated ~27% regional share.

Vascular Grafts Market Segmentation Analysis

To learn more about this report, Download Free Sample

Vascular Grafts Market Insights, By Product Type

Synthetic grafts dominate the market, holding around 65% share due to widespread use of ePTFE, polyester, and PTFE materials with strong durability and clinical familiarity. Biological grafts hold about ~20% share, valued for biocompatibility and reduced immunogenicity in specific applications. Composite/biosynthetic grafts make up approximately ~15%, driven by innovation combining mechanical strength with better tissue integration. This distribution reflects surgeon preference for proven synthetic options alongside growing interest in hybrid solutions.

Vascular Grafts Market Insights, By Technology

The vascular grafts market is increasingly shaped by endovascular technologies, with Endovascular stent grafts capturing 64% share due to their minimally invasive advantages and broad use in aneurysm repair. Open surgical grafts and traditional Bypass grafts account for the remainder, offering established clinical performance where endovascular access is limited. Emerging 3D‑printed and tissue‑engineered graft technologies, integrating bioresorbable materials and personalized designs, are forecast to grow rapidly, representing a rising segment of innovation (projected double‑digit growth). This technological shift emphasizes less invasive procedures and customized graft solutions, enhancing patient outcomes and expanding procedural adoption.

Vascular Grafts Market Insights, By End-User

Hospitals dominate end‑user demand, holding roughly ~65% share due to comprehensive surgical capabilities, advanced imaging, and ability to manage complex procedures. They remain the primary site for both traditional and minimally invasive vascular graft interventions. Ambulatory surgical centers (ASCs) account for about ~20% share, expanding as outpatient and minimally invasive procedures grow in popularity because of cost efficiency and faster recovery. Specialized clinics/other end users represent the remaining ~15%, supported by niche cardiovascular care and personalized treatment models. This segmentation reflects shifting care delivery while hospitals maintain leadership.

Vascular Grafts Market Trends

• Endovascular stent grafts are increasingly preferred over open surgery due to reduced recovery times, lower complication rates, and broader clinical adoption worldwide.

• Growth in bioengineered, hybrid, drug‑eluting, and personalized vascular grafts using advanced biomaterials (e.g., ePTFE, tissue‑engineered scaffolds) is improving biocompatibility, patency, and long‑term outcomes.  

• The increasing prevalence of cardiovascular diseases, peripheral artery disease, and end‑stage renal disease has boosted demand for bypass and hemodialysis access grafts globally.  

Vascular Grafts Market Insights, By Geography

To learn more about this report, Download Free Sample

North America Vascular Grafts Market Analysis and Trends

The North America vascular grafts market leads globally, holding about 40% share of the global market thanks to advanced healthcare infrastructure, high cardiovascular disease prevalence, and strong procedural volumes. The United States dominates, contributing the majority of regional demand, while Canada plays a growing role driven by dialysis access needs. Endovascular stent grafts represent the largest product segment, supported by widespread use in aneurysm repair.

Asia Pacific Vascular Grafts Market Analysis and Trends

The Asia Pacific vascular grafts market is among the fastest‑growing globally, representing around 25% of the global market share due to rising cardiovascular disease prevalence, expanding healthcare access, and modernized surgical infrastructure in countries like China, India, and Japan. Increased incidence of diabetes and kidney disease further boosts need for dialysis access grafts. Investment in advanced graft technology adoption and hybrid operating theaters is accelerating procedural volumes and market expansion.

Vascular Grafts Market Outlook for Key Countries

USA Vascular Grafts Market Analysis and Trends

The U.S. vascular grafts market is growing due to rising cardiovascular diseases, diabetes, and end‑stage renal disease. Synthetic grafts like PTFE dominate because of durability and performance. Innovations in biocompatible, hybrid, and tissue‑engineered grafts and supportive reimbursement in advanced healthcare settings continue to fuel market expansion.

Germany Vascular Grafts Market Analysis and Trends

The Germany vascular grafts market is growing, driven by high volumes of cardiovascular and peripheral vascular procedures and advanced surgical centers. Synthetic grafts dominate due to durable performance and broad clinical use. Growing prevalence of coronary artery disease and aneurysms fuels consistent demand, supported by strong public healthcare and reimbursement systems. Innovation in minimally invasive and biosynthetic graft technologies is expanding procedures in specialized vascular units. Germany’s established hospital infrastructure and early detection programs further enhance market momentum and technology adoption.

Analyst Opinion

• Rising prevalence of cardiovascular diseases, peripheral artery disease, and end-stage renal disease ensures continuous demand for vascular grafts globally.

• Endovascular stent grafts are increasingly preferred over open surgery due to reduced recovery times, lower complications, and patient preference.  

• Bioengineered, hybrid, and tissue-engineered grafts are expected to capture growing market share, offering improved biocompatibility and long-term patency.  

• North America dominates, while Asia Pacific presents the fastest growth due to rising healthcare infrastructure and disease prevalence.  

• High cost, reimbursement variability, and potential graft complications remain barriers, requiring continued R&D and clinical validation.

Market Scope

Vascular Grafts Market Growth Factors

The vascular grafts market is expanding due to the rising prevalence of cardiovascular diseases, peripheral artery disease, aneurysms, and end-stage renal disease requiring hemodialysis. Aging populations in developed and emerging regions increase demand for vascular interventions. Technological advancements, including bioengineered, tissue-engineered, and minimally invasive endovascular grafts, improve patient outcomes and procedural adoption. Growing awareness and early diagnosis of vascular disorders further drive market penetration. Favorable reimbursement policies and increasing hospital infrastructure, especially in North America and Asia Pacific, support accessibility. Additionally, the shift toward outpatient procedures and hybrid surgical approaches fuels consistent market growth globally.

Vascular Grafts Market Development

In August 2025, Aquedeon Medical announced that the US Food and Drug Administration (FDA) approved an expansion of the investigational device exemption (IDE) clinical trial for its Duett vascular graft system. Duett is a novel device intended to support open surgical repair of aortic arch aneurysms and dissections, including use in hybrid procedures.

Key Players

Leading Companies of the Market

• Medtronic

• Terumo Corporation

• Getinge AB

• W. L. Gore & Associates

• LeMaitre Vascular

• BD (Becton Dickinson)

Key players in the vascular grafts market include Medtronic, Terumo Corporation, Getinge AB, W. L. Gore & Associates, LeMaitre Vascular, BD (Becton Dickinson), leading innovation and global distribution in graft materials and technologies.

Vascular Grafts Market Future Outlook

The vascular grafts market is poised for steady growth, driven by rising cardiovascular disease prevalence, aging populations, and increasing incidence of renal disorders requiring dialysis. Endovascular and minimally invasive procedures are expected to gain further traction, supported by technological advancements in bioengineered, tissue-engineered, and hybrid grafts. Emerging markets, particularly in Asia Pacific and Latin America, present significant growth opportunities due to expanding healthcare infrastructure and rising procedural awareness. Strategic collaborations, R&D investments, and favorable reimbursement policies will enhance accessibility and adoption. Overall, the market outlook is positive, with innovation and demographic trends shaping a robust future trajectory.

Vascular Grafts Market Historical Analysis

Historically, the vascular grafts market evolved from the use of autologous vein grafts to the development of synthetic materials such as Dacron and ePTFE in the mid-20th century, significantly improving surgical outcomes. During the 1990s and early 2000s, advancements in endovascular stent graft technology transformed aneurysm repair, reducing reliance on open surgery. Market growth accelerated with rising cases of cardiovascular disease and expanded dialysis access procedures.

Sources

• Primary Research Interviews:

• C-Level Executives (CEO, CFO, COO)

• Vice Presidents & Directors

• Product Managers & Marketing Managers

• R&D Specialists & Biomedical Engineers

• Databases:

• PubMed

• ClinicalTrials.gov

• World Health Organization

• Journals:

• Journal of Vascular Surgery

• European Journal of Vascular and Endovascular Surgery

• Annals of Vascular Surgery

• Journal of Endovascular Therapy

• Newspapers:

• The Wall Street Journal

• Financial Times

• The Guardian

• The New York Times

• Associations:

• Society for Vascular Surgery (SVS)

• European Society for Vascular Surgery (ESVS)

• American Heart Association (AHA)

• American College of Cardiology (ACC)